Vivimed Labs Limited (VIVIMEDLAB) — Secretarial Compliance

· NSE Neutral

Vivimed Labs Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026 to BSE and NSE on May 19, 2026. The report, signed by Practicing Company Secretary N.V.S.S.Suryanarayana Rao (ACS No.5868 & CP No.2886), confirms compliance with all applicable SEBI regulations, listing obligations, and corporate governance norms. It details verification of statutory filings, website disclosures, board processes, and related party transaction protocols. No material non-compliances or penalties were observed, and no SEBI actions were taken during the review period. The filing reaffirms the company’s adherence to SEBI LODR and regulatory disclosure requirements.

📄 View Original Announcement (PDF)

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹61.27 Cr P/E: -4.4

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day